dr. marshall on single-agent and combination immunotherapy applications in msi-h mcrc
Published 6 years ago • 133 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
4:00
immunotherapy combinations in msi and mss mcrc
-
6:27
immunotherapy in msi-high pancreatic tumors
-
5:48
emerging immunotherapy combinations in mss crc
-
8:34
relapsed/refractory mcrc: immunotherapy in msi-high tumors
-
4:32
immunotherapy regimens in dmmr/msi-high metastatic crc
-
1:04
dr. marshall on the importance of testing for braf mutations in mcrc
-
5:49
immunotherapy and msi status in colorectal cancer
-
9:02
pembrolizumab in msi-h crc tumors
-
0:43
immunotherapy in msi-h/dmmr mcrc: first-line options and dual checkpoint inhibition insights
-
1:07
dr. bendell on the next steps following progression on immunotherapy in msi-h crc
-
9:25
debate: msi high colon cancer - immunotherapy
-
1:15
dr. mcdermott on single-agent versus combination immunotherapy in rcc
-
1:39
dr. marshall on the safety profile of y-90 in colorectal cancer
-
1:03
dr. nelson on the checkmate-142 trial in msi-h/dmmr mcrc
-
0:58
dr. overman discusses immunotherapy and msi testing in crc
-
3:27
crc: emerging immunotherapy strategies in mss tumors
-
1:35
dr. chu on the role of pembrolizumab in dmmr/msi-h mcrc
-
8:04
using i/o in msi-h tumors in mcrc